Dr. Leath on Ongoing Trials for Endometrial Cancer

Charles A. (Trey) Leath, III, MD, associate professor, UAB School of Medicine, UAB Comprehensive Cancer Center, discusses ongoing trials for patients with endometrial cancer.

Endometrial cancer is the most common gynecologic cancer, explains Leath. However, there is a lot that is unknown regarding the ideal treatment for endometrial cancer.

The PORTEC-3 and GOG 258 compared chemotherapy with various approaches of chemoradiation therapy. Standard chemotherapy has been beneficial; however, the role of radiation needs to be investigated further, states Leath.